TARRYTOWN, N.Y.--(BUSINESS WIRE)--Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) today announced the election of board member Peter J. Crowley as Chairman of the Board at the Company’s annual meeting. Mr. Crowley replaces Kurt Briner, who is stepping down as Chairman at the end of his term while remaining a director. Mr. Crowley has over two decades of experience in healthcare finance as a senior investment banker. During his career as an investment banker Mr. Crowley often advised Progenics.
